BETAGENON AB
Betagenon is a biotechnology company focused on the development of AMP-activated protein kinase (AMPK) activator compounds to treat chronic energy balance disorders diseases in metabolically challenged elderly and/or obese individuals. Drugs that activate AMPK are expected to have beneficial effects on metabolic and cardiovascular diseases and on certain cancers. Their lead AMPK activator compound O304 is currently in Phase IIa clinical trial.
BETAGENON AB
Social Links:
Industry:
Biotechnology Health Care Medical
Founded:
2001-01-01
Address:
Umeå, Vasterbottens Lan, Sweden
Country:
Sweden
Website Url:
http://www.betagenon.se
Total Employee:
1+
Status:
Active
Contact:
+46 90154822
Email Addresses:
[email protected]
Total Funding:
4.02 M USD
Technology used in webpage:
SPF Microsoft Exchange Online Office 365 Mail Microsoft Azure DNS Levonline
Similar Organizations
PIQUR Therapeutics
PIQUR Therapeutics is a Swiss pharmaceutical company focusing on the discovery and development of anti-cancer drugs.
Current Employees Featured
Founder
Investors List
MCG Technology Group
MCG Technology Group investment in Venture Round - Betagenon AB
EASME - EU Executive Agency for SMEs
EASME - EU Executive Agency for SMEs investment in Grant - Betagenon AB
Official Site Inspections
http://www.betagenon.se
- Host name: ing.r101.websupport.se
- IP address: 109.235.174.3
- Location: Sweden
- Latitude: 59.3247
- Longitude: 18.056
- Timezone: Europe/Stockholm
